Kim-Hien Dao
Chief Medical OfficerDr. Kim-Hien Dao, D.O., Ph.D., is Chief Medical Officer of Electra Therapeutics, Inc. from May 2024. Dr. Dao joined the Electra Therapeutics, Inc. in April 2023 as Vice President, Head of Clinical Development. Prior to joining Electra, she was Executive Medical Director at Astex Pharmaceuticals, where she worked on four drug programs for solid tumors and hematological malignancies. Previously, she had a tenure at Oregon Health and Science University (OHSU) and had a clinical focus in myelodysplastic syndromes, myeloproliferative neoplasms, bone marrow failure syndromes, bone marrow transplant and clonal hematopoiesis. She also ran a research laboratory that was funded by the National Institutes of Health and the OHSU Knight Cancer Institute. She is a clinician scientist with clinical and translational research experience in academia and biotech. Dr. Dao received her DO, PhD in Biochemistry and Molecular Biology from Michigan State University and trained in Hematology-Medical Oncology at the University of California at San Diego.
Positions
- Company NameElectra Therapeutics, Inc.Stock CodeETRAPositionChief Medical Officer
